DexCom develops, manufactures and distributes continuous glucose monitoring systems for diabetes management.Read more
Dexcom's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 11.1B. Over the last four quarters, Dexcom's revenue has grown by 5.7%. Specifically, in Q1 2022's revenue was $628.8M; in Q4 2021, it was $698.2M; in Q3 2021, it was $650.2M; in Q2 2021, Dexcom's revenue was $595.1M.